[Large studies of NOAC shows good and safe stroke protection].
Akademiska sjukhuset - Kardiologkliniken Uppsala, Sweden Akademiska sjukhuset - Kardiologkliniken Uppsala, Sweden.
Ziad
Z
Hijazi
Akademiska sjukhuset - Kardiologkliniken Uppsala, Sweden Akademiska sjukhuset - Kardiologkliniken Uppsala, Sweden.
Jonas
J
Oldgren
D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use; D000991:Antithrombins / Q000494:pharmacology / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D065427:Factor Xa Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use; D011728:Pyridones / Q000494:pharmacology / Q000627:therapeutic use; D012307:Risk Factors; D000069552:Rivaroxaban / Q000494:pharmacology / Q000627:therapeutic use; D020521:Stroke / Q000517:prevention & control*; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use; D014859:Warfarin / Q000494:pharmacology / Q000627:therapeutic use
D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D011728:Pyridones; D013844:Thiazoles; C522181:apixaban; D014859:Warfarin; D000069552:Rivaroxaban; C552171:edoxaban